COVID-19 antiviral: FDA oks human clinical trials for EIDD-2801
by Press Release from Outbreak News Today on (#51WBH)
Human clinical trials may begin on an antiviral compound which was discovered and developed by Emory University and shows promise as a potential treatment for COVID-19. The U.S. Food and Drug Administration (FDA) has approved an Investigational New Drug application by Drug Innovation Ventures at Emory (DRIVE), LLC, wholly owned by Emory University, for EIDD-2801. ["]
The post COVID-19 antiviral: FDA oks human clinical trials for EIDD-2801 appeared first on Outbreak News Today.